The ARRB1 Antibody (e.g., Affinity Biosciences Cat# AF7810) is a rabbit polyclonal antibody targeting the 50 kDa β-arrestin-1 protein . It is validated for western blot (WB) applications and reacts with human, mouse, and rat samples, with cross-reactivity predicted in pigs, zebrafish, and other vertebrates . ARRB1 is a cytosolic/nuclear scaffold protein involved in G-protein-coupled receptor (GPCR) signaling, receptor desensitization, and immune modulation .
ARRB1 regulates GPCR signaling by:
Scaffolding signaling intermediates like AKT1, ERK1/2, and p38 MAPK .
Modulating immune cell functions, including T-lymphocyte survival and macrophage activity .
Influencing autophagy and apoptosis under stress conditions (e.g., cerebral ischemia) .
ARRB1 exhibits dual roles in tumor progression:
| Clinical Parameter | High ARRB1 (%) | Low ARRB1 (%) | P-value |
|---|---|---|---|
| Tumor Size >4 cm | 62.5 | 37.5 | 0.015* |
| Lymphatic Metastasis | 66.7 | 33.3 | 0.009* |
| TNM Stage III/IV | 54.3 | 45.7 | 0.052 |
High ARRB1 correlates with aggressive GBC phenotypes, promoting proliferation via TAK1/MAPK signaling . In contrast, ARRB1 suppresses triple-negative breast cancer growth by enhancing histone acetylation at the Bcl-2 promoter .
ARRB1 deficiency exacerbates neuronal injury during ischemia by impairing autophagy. It interacts with BECN1 and PIK3C3 to facilitate autophagosome formation, reducing apoptosis .
ARRB1 enhances CD4+ T-cell survival and modulates TCR-mediated cAMP/PKA signaling, influencing antitumor immunity .
ARRB1 Antibody is utilized to: